Innovation in oncology clinical trial design - Cancer Treatment Reviews
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee | Journal for ImmunoTherapy of Cancer
Top 5 challenges of immuno-oncology clinical trials -
Recruiting and Retaining Minorities in Oncology Clinical Trials: A Nurse Navigator Perspective - Journal of Oncology Navigation & Survivorship
Clinical Trials: A Look at Recent Progress | University of Utah Health
5 Things to Know About Clinical Trials in Cancer Treatment | Fox Chase Cancer Center - Philadelphia, PA
Why Are Cancer Clinical Trials Increasing in Duration?
Cancer Clinical Trials - Cancer Care | St. Luke's Cancer Center
Rethinking cancer clinical trials for COVID-19 and beyond | Nature Cancer
Oncology Clinical Trials During the COVID-19 Pandemic
New Alliance formed to address clinical trials in oncology | The Bulletin
COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective - Marcum - 2020 - Cancer Medicine - Wiley Online Library
Oncology clinical trials by number of biomarkers global 2012-2018 | Statista
Landscape of Oncology Clinical Trials in Africa | JCO Global Oncology
Improving Oncology Clinical Trial Participation and Experience: Trends in Cancer
Randomization and Bias in Cancer Clinical Trials - NCI
COVID-19's Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis - Cancer Research Institute (CRI)
Oncology Clinical Trials
Oncology Clinical Trials During the COVID-19 Pandemic
NCI's National Clinical Trials Network (NCTN) - NCI
Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review - The Lancet Oncology
Clinical Protocols | Divisions of Hematology & Oncology | Washington University in St. Louis
Oncology dominates clinical trials activity in 2020, says GlobalData - GlobalData
Clinical Trials and Cancer Research | Texas Oncology
COVID-19 impact on oncology clinical trials: a 1-year analysis
Keep some pandemic-initiated changes to cancer clinical trials, task force members urge
